These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 9396393

  • 1. Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas.
    Chamberlain MC, Kormanik PA.
    J Clin Oncol; 1997 Dec; 15(12):3427-32. PubMed ID: 9396393
    [Abstract] [Full Text] [Related]

  • 2. Salvage chemotherapy with paclitaxel for recurrent primary brain tumors.
    Chamberlain MC, Kormanik P.
    J Clin Oncol; 1995 Aug; 13(8):2066-71. PubMed ID: 7636549
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Salvage chemotherapy with CPT-11 for recurrent oligodendrogliomas.
    Chamberlain MC.
    J Neurooncol; 2002 Sep; 59(2):157-63. PubMed ID: 12241109
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
    Soffietti R, Nobile M, Rudà R, Borgognone M, Costanza A, Laguzzi E, Mutani R.
    Cancer; 2004 Feb 15; 100(4):807-13. PubMed ID: 14770438
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR, Aghajanian C, Barakat RR, Fennelly D, Shapiro F, Spriggs D.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [Abstract] [Full Text] [Related]

  • 9. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
    Zander T, Nettekoven W, Kraus JA, Pels H, Ko YD, Vetter H, Klockgether T, Schlegel U.
    J Neurol; 2002 Aug 15; 249(8):1055-7. PubMed ID: 12195453
    [Abstract] [Full Text] [Related]

  • 10. Salvage chemotherapy with tamoxifen for recurrent anaplastic astrocytomas.
    Chamberlain MC, Kormanik PA.
    Arch Neurol; 1999 Jun 15; 56(6):703-8. PubMed ID: 10369310
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E, Guastalla JP, Weber B, Curé H, Orfeuvre H, Mousseau M, Vincent P, Diéras V, Tubiana-Mathieu N, Jacquin JP, Mignot L, Leduc B, Paraïso D, Viens P.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [Abstract] [Full Text] [Related]

  • 12. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.
    Soffietti R, Rudà R, Bradac GB, Schiffer D.
    Neurosurgery; 1998 Nov 15; 43(5):1066-73. PubMed ID: 9802850
    [Abstract] [Full Text] [Related]

  • 13. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
    Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B.
    J Neurosurg; 1992 May 15; 76(5):741-5. PubMed ID: 1564535
    [Abstract] [Full Text] [Related]

  • 14. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC, Glantz MJ.
    Neurosurgery; 2008 Oct 15; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [Abstract] [Full Text] [Related]

  • 15. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas.
    Kim L, Hochberg FH, Thornton AF, Harsh GR, Patel H, Finkelstein D, Louis DN.
    J Neurosurg; 1996 Oct 15; 85(4):602-7. PubMed ID: 8814163
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
    Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C.
    J Clin Oncol; 1994 Oct 15; 12(10):2013-21. PubMed ID: 7931469
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of paclitaxel in patients with recurrent malignant glioma.
    Prados MD, Schold SC, Spence AM, Berger MS, McAllister LD, Mehta MP, Gilbert MR, Fulton D, Kuhn J, Lamborn K, Rector DJ, Chang SM.
    J Clin Oncol; 1996 Aug 15; 14(8):2316-21. PubMed ID: 8708723
    [Abstract] [Full Text] [Related]

  • 18. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I, Biron P, Bachelot T, Guastalla JP, Catimel G, Merrouche Y, Droz JP, Chauvin F, Blay JY.
    Cancer; 1998 Jan 01; 82(1):134-40. PubMed ID: 9428489
    [Abstract] [Full Text] [Related]

  • 19. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
    Webre C, Shonka N, Smith L, Liu D, De Groot J.
    Anticancer Res; 2015 Oct 01; 35(10):5467-72. PubMed ID: 26408710
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
    Hurwitz CA, Strauss LC, Kepner J, Kretschmar C, Harris MB, Friedman H, Kun L, Kadota R.
    J Pediatr Hematol Oncol; 2001 Oct 01; 23(5):277-81. PubMed ID: 11464982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.